Properties (70)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:approves |
treatment of hypertension
|
| gptkbp:chemicalFormula |
C12H14N2O3S
|
| gptkbp:developedBy |
gptkb:XYZ_Pharmaceuticals
|
| gptkbp:hasFilm |
dizziness
fatigue nausea |
| gptkbp:hasHistory |
12 hours
|
| gptkbp:hasMerchandise |
angiotensin receptor blocker
|
| gptkbp:hasPerformedAt |
tablet
|
| gptkbp:hasTitle |
Hypertensol
|
| gptkbp:hasWeight |
270.32 g/mol
|
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-201
|
| gptkbp:isActiveIn |
research studies
|
| gptkbp:isAssociatedWith |
patient adherence
lowering blood pressure |
| gptkbp:isAttendedBy |
oral route
pH adjustments |
| gptkbp:isAvailableIn |
generic drug
|
| gptkbp:isChallengedBy |
liver enzymes
|
| gptkbp:isCompatibleWith |
alcohol
other antihypertensives |
| gptkbp:isConsidered |
first-line treatment
safe for most patients |
| gptkbp:isDiscussedIn |
medical conferences
pharmacology textbooks |
| gptkbp:isDocumentedIn |
medical literature
clinical trials registry |
| gptkbp:isEvaluatedBy |
patient outcomes
cost-effectiveness clinical efficacy long-term safety |
| gptkbp:isIncorporatedIn |
urine
|
| gptkbp:isInformedBy |
excipients
|
| gptkbp:isLinkedTo |
quality of life improvements
improved cardiovascular outcomes |
| gptkbp:isMarketedAs |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:isPartOf |
treatment protocols
placebo multidisciplinary care teams treatment guidelines cardiovascular drugs other antihypertensives drug formulary antihypertensive therapy therapeutic classes |
| gptkbp:isRecognizedFor |
medical guidelines
elderly patients children under 18 |
| gptkbp:isReferencedIn |
clinical guidelines
healthcare policies |
| gptkbp:isStudiedIn |
heart failure
adverse effects drug interactions |
| gptkbp:isSubjectTo |
market surveillance
regulatory review patent laws |
| gptkbp:isUsedIn |
clinical practice
outpatient settings healthcare_settings |
| gptkbp:isUtilizedFor |
diabetes management
comorbid conditions |
| gptkbp:isUtilizedIn |
clinical trials
treatment algorithms |
| gptkbp:isValuedFor |
chronic kidney disease
|
| gptkbp:training |
pregnancy
severe liver impairment |
| gptkbp:usedIn |
pharmaceutical applications
|